A year ago, we asked healthcare leaders for their thoughts on the future of the PBM industry. Healthcare leaders were divided on whether the largest PBMs would continue to dominate or whether new, smaller PBMs would reshape the market. Most predicted a scenario that was a combination of both, and we’re beginning to see that future take shape.

Recent headlines on Blue Cross Blue Shield of California’s (BSC) decision indicate that pharmacy disruptors may be starting to find traction and that the largest PBMs are vulnerable in ways that they haven’t been in the past. A statement from BSC pointed to a desire for less complexity and more transparency as driving this change. Here are our three biggest takeaways from this decision and how they may create a new blueprint for pharmacy benefit management in years to come.